Singlon - instructions for use, analogs, reviews and release forms (10 mg tablets, chewing 4 mg and 5 mg) medications for the treatment and prevention of bronchial asthma, including aspirin in adults, children and pregnancy. Composition
In this article, you can read the instructions for using the drug Singlon. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Singlon in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Singlon in the presence of existing structural analogues. Use for the treatment and prevention of bronchial asthma,including Aspirin and bronchospasm in adults, children, as well as during pregnancy and lactation. Composition of the preparation.
Singlon - a specific antagonist of leukotriene receptors for oral administration. Montelukast (active ingredient of the preparation Singlon) has the ability to inhibit bronchospasm due to the inhalation of LTD4 in very low doses (5 mg). Bronchodilation is observed within 2 hours after ingestion. The effect of bronchodilation, caused by beta-adrenomimetic, is supplemented by the action of montelukast. Singlon inhibits the early and late phases of bronchoconstriction caused by the introduction of antigen. Montelukast reduces the number of eosinophils in the peripheral blood, in the respiratory tract (in sputum) of adult patients and children and improves control over the course of bronchial asthma.
Montelukast significantly improves the morning FEV (volume of forced exhalation) for 1 second, MOSV (maximum volumetric expiratory flow rate) and significantly reduces the need for beta-adrenomimetics.
Singlon enhances the effect of inhaled glucocorticosteroids. Montelukast significantly weakens bronchospasm, which occurs against the background of physical activity.In patients with bronchial asthma, sensitive to Acetylsalicylic acid and taking concomitant inhalation and / or oral glucocorticosteroids, treatment with montelukast leads to a significant improvement in the control of symptoms of bronchial asthma.
Composition
Montelukast sodium + excipients.
Pharmacokinetics
Singlon is quickly absorbed after ingestion. On average, the bioavailability after oral administration is 64%. Eating does not affect bioavailability. Montelukast is more than 99% bound to plasma proteins. The drug penetrates poorly through the blood-brain barrier. Concentrations of montelukast 24 hours after application of the drug were minimal in all tissues of the body. Exposed to intensive metabolism. When therapeutic doses are used, the concentration of metabolites of montelukast in plasma in equilibrium in adults and children is not determined. The contribution of metabolites to the therapeutic effect of montelukast is minimal. After taking montelukast, 86% of the drug is taken out through the intestine and less than 0.2% by the kidneys. The drug and its metabolites are excreted mainly with bile.
For the elderly, patients with mild or moderate hepatic insufficiency, dose adjustment is not required.
Indications
- long-term treatment and prevention of bronchial asthma (including the prevention of day and night symptoms of the disease);
- treatment of "aspirin" asthma and prevention of bronchospasm of physical effort.
Forms of release
The tablets covered with a cover of 10 mg.
Tablets chewing 4 mg and 5 mg (children 2-5 years (tablets chewing 4 mg) and children 6-14 years (tablets chewing 5 mg)).
Instructions for use and dosing regimen
Tablets 10 mg
Inside.
Adults and adolescents aged 15 years and over to treat bronchial asthma take 1 tablet of the drug Singlon 10 mg daily in the evening, regardless of food intake.
General recommendations
The therapeutic effect of the drug Singlon on the symptoms associated with bronchial asthma, manifests itself within one day. The patient is recommended to continue taking the drug Singlon both during periods of controlled course of bronchial asthma and during periods of worsening of the course of the disease.
The drug Singlon should not be taken together with other drugs containing the same active substance - Montelukast.
In elderly patients with mild or moderate renal insufficiency, hepatic insufficiency does not require correction of the dose. Data for patients with severe hepatic insufficiency are absent.
The dose of the drug is the same for both female and male patients.
The drug Singlon can be included in existing regimens for the treatment of bronchial asthma.
Inhaled glucocorticosteroids: Synngon is prescribed for the treatment of bronchial asthma as an additional therapy for patients in whom inhaled glucocorticosteroids and short-acting beta-adrenomimetics, if necessary, do not provide the necessary clinical control of the disease. Montelukast should not replace inhaled glucocorticosteroids.
For children aged 6 to 14 years, 5 mg of chewable tablets are used.
Tablets chewing for children
For children aged 2-5 years, the preparation Singlon is prescribed 1 tablet chewing 4 mg daily in the evening.
For children aged 6-14 years, the preparation Singlon is prescribed 1 tablet of chewing 5 mg daily in the evening.
The drug Singlon should be taken 1 hour before or 2 hours after eating. Dose adjustments within these age groups are not required.
The safety and efficacy of chewable tablets of 4 mg for children under 2 years of age have not been established.
General recommendations
The therapeutic effect of the drug Singlon develops within one day after admission. The patient should continue taking the drug Singlon both during periods of controlled course of bronchial asthma, and during periods of worsening of the course of the disease.
In patients with renal insufficiency, mild or moderate degree of hepatic insufficiency, dose adjustment is not required. Data for patients with severe hepatic impairment are not available.
The dose of the drug does not depend on the sex of the patient.
Therapy with the drug Singlon in combination with other drugs for the treatment of bronchial asthma
If the drug Singlon is appointed against the background of ingestion of glucocorticosteroids (GCS), then you should not suddenly replace inhaled glucocorticosteroids with the drug Singlon.
Side effect
- increased tendency to bleeding;
- hypersensitivity reactions, including anaphylaxis;
- eosinophilic liver infiltrates;
- sleep disturbances, including nightmares, hallucinations, insomnia;
- irritability;
- anxiety;
- Excitement, including aggressive behavior;
- tremor;
- depression;
- suicidal thoughts and suicidal behavior (suicidal);
- headache;
- dizziness;
- drowsiness;
- paresthesia / hypoesthesia;
- convulsive seizures;
- cardiopalmus;
- stomach ache;
- diarrhea;
- dry mouth;
- dyspepsia;
- nausea, vomiting;
- increased activity of transaminases in blood serum (alanine aminotransferase, aspartate aminotransferase);
- cholestatic hepatitis;
- angioedema;
- the appearance of ecchymoses;
- hives;
- itching;
- rash;
- nodular erythema;
- arthralgia;
- Myalgia, including muscle spasms;
- thirst;
- asthenia / increased fatigue;
- discomfort;
- edema.
Contraindications
- hypersensitivity to the active substance or to any of the excipients;
- children under 15 years (for tablets 10 mg);
- children under 2 years of age (for chewing tablets 4 mg);
- children under 6 years of age (for 5 mg chewing tablets);
- lactose intolerance, lactase deficiency, glucose-galactose malabsorption.
With caution: pregnancy and lactation.
Application in pregnancy and lactation
The drug Singlon can be used during pregnancy and during breastfeeding, if the expected benefit for the mother exceeds the potential risk to the fetus and the baby.
Use in children
Contraindicated in children and adolescents under the age of 15 years.
For children aged 6 to 14 years, 5 mg of chewable tablets are used.
For children aged 2 to 5 years, chewable tablets of 4 mg are used.
Application in elderly patients
In elderly patients with mild or moderate renal insufficiency, dose adjustment is not required.
special instructions
The drug Singlon should not replace inhaled or oral glucocorticosteroids.
There is no data suggesting the possibility of reducing the dose of oral glucocorticosteroids with the concomitant use of the drug Singlon.
In rare cases, systemic eosinophilia, sometimes accompanied by clinical manifestations of vasculitis and Chang-Strauss syndrome, may occur in patients taking medications for the treatment of bronchial asthma, including the Singlon drug; this condition is usually treated with systemic glucocorticosteroids.Such cases are usually, but not always, associated with a decrease in dose or with the elimination of oral glucocorticosteroids. We can neither exclude nor confirm the possibility that the administration of leukotriene receptor antagonists may be associated with the onset of the Chang-Strauss syndrome. Doctors should be aware of the possibility of patients developing eosinophilia, vasculitic rash, an increase in pulmonary symptoms, complications from the heart and / or neuropathy. Patients who have the above symptoms should undergo a second examination, and their treatment regimen should be reviewed.
Receiving the drug Singlon does not affect the intake of acetylsalicylic acid and other non-steroidal anti-inflammatory drugs in patients with bronchial asthma with increased sensitivity to acetylsalicylic acid.
The drug contains lactose, so it should not be taken to patients with such rare hereditary diseases as lactose intolerance, lactase deficiency, glucose-galactose malabsorption.
Effect of the drug on the ability to drive vehicles and mechanisms
It is assumed that the drug Singlon does not affect the ability to drive or other mechanisms. However, in very rare cases, patients were drowsy.
Drug Interactions
The drug Singlon can be administered in conjunction with other drugs traditionally prescribed for the prevention and long-term treatment of bronchial asthma. The drug at recommended doses had no clinically significant effect on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (ethinylestradiol / norethisterone 35/1), terfenadine, Digoxin and warfarin.
AUC montelukast in plasma was reduced by approximately 40% in patients who took montelukast and phenobarbital. Since CYP3A4 is involved in the metabolism of montelukast, caution should be exercised, especially in children, when using montelukast with CYP3A4 inducers such as phenytoin, Phenobarbital and rifampicin.
Studies have shown that montelukast is a potent inhibitor of CYP2C8. However, the results of a study of the clinical interaction of montelukast and rosiglitazone (an example of marker substrates for drugs,the main metabolism of which is carried out by the enzyme CYP2C8) did not reveal the inhibitory effect of montelukast on CYP2C8. Therefore, it is expected that montelukast will not significantly change the conversions of drugs that are metabolized with the participation of this enzyme (for example, paclitaxel, rosiglitazone and repaglinide). When taking high doses of montelukast (at a 20- and 60-fold excess of the recommended dose for adults), a decrease in the concentration of theophylline in the plasma is observed. This effect is not observed when taking the drug at recommended doses - 10 mg per day.
Analogues of the drug Singlon
Structural analogs for the active substance:
- Monax;
- Moncast;
- Montelar;
- Montelast;
- Montelukast;
- Simpler;
- Singulex;
- Singular;
- Ektalust.
Similar medicines:
Other medicines:
- Implanon - instructions for use, analogs, reviews and release forms (implant subcutaneous 68 mg, NCST) of the drug for contraception and prevention of pregnancy in women. Side effects and use in breastfeeding, drug administration
- Tornethis - instructions for use, reviews, analogs and formulations (tablets 25 mg, 50 mg and 100 mg) of the drug for the treatment of erectile dysfunction, decreased potency or impotence in men. Composition and alcohol
- Minolexin - instructions for use, reviews, analogs and forms of release (capsules or tablets 50 mg and 100 mg) antibiotic medicines for the treatment of acne or acne, sore throats, pneumonia in adults, children and in pregnancy